Cost-effectiveness analysis of apixaban compared to low-molecular-weight heparins and Vitamin K antagonists for treatment and secondary prevention of venous thromboembolism

  1. Elías, I.
  2. Oyagüez, I.
  3. Álvarez-Sala, L.A.
  4. García-Bragado, F.
  5. Navarro, A.
  6. González, P.
  7. De Andrés-Nogales, F.
  8. Soto, J.
Aldizkaria:
Farmacia Hospitalaria

ISSN: 2171-8695 1130-6343

Argitalpen urtea: 2016

Alea: 40

Zenbakia: 3

Orrialdeak: 187-208

Mota: Berrikuspena

DOI: 10.7399/FH.2016.40.3.10461 GOOGLE SCHOLAR